rs139228801
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_001232.4(CASQ2):c.923C>T(p.Pro308Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000633 in 1,612,276 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P308Q) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001232.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CASQ2 | ENST00000261448.6 | c.923C>T | p.Pro308Leu | missense_variant | Exon 9 of 11 | 1 | NM_001232.4 | ENSP00000261448.5 | ||
CASQ2 | ENST00000488931.2 | n.*295C>T | non_coding_transcript_exon_variant | Exon 11 of 13 | 3 | ENSP00000518226.1 | ||||
CASQ2 | ENST00000488931.2 | n.*295C>T | 3_prime_UTR_variant | Exon 11 of 13 | 3 | ENSP00000518226.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152220Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251362Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135846
GnomAD4 exome AF: 0.0000658 AC: 96AN: 1460056Hom.: 1 Cov.: 30 AF XY: 0.0000661 AC XY: 48AN XY: 726490
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74368
ClinVar
Submissions by phenotype
Catecholaminergic polymorphic ventricular tachycardia 2 Pathogenic:2
- -
- -
not provided Pathogenic:1
Not observed at significant frequency in large population cohorts (gnomAD); Published in vitro functional studies suggest this variant results in loss of ion selectivity and alteration of surface charge distribution (PMID: 21265816); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 24025405, 27538377, 22553997, 18684293, 32693635, 34495297, 34257423, 21265816) -
Catecholaminergic polymorphic ventricular tachycardia 1 Pathogenic:1
This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 308 of the CASQ2 protein (p.Pro308Leu). This variant is present in population databases (rs139228801, gnomAD 0.005%). This missense change has been observed in individual(s) with catecholaminergic polymorphic ventricular tachycardia (PMID: 18684293, 22553997). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 190755). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CASQ2 protein function. Experimental studies have shown that this missense change affects CASQ2 function (PMID: 21265816). For these reasons, this variant has been classified as Pathogenic. -
Cardiovascular phenotype Pathogenic:1
The p.P308L variant (also known as c.923C>T), located in coding exon 9 of the CASQ2 gene, results from a C to T substitution at nucleotide position 923. The proline at codon 308 is replaced by leucine, an amino acid with similar properties. This variant was previously detected in conjunction with another alteration in CASQ2 in a compound heterozygous individual with catecholaminergic polymorphic ventricular tachycardia (CPVT), and the occurrence of this variant was described as de novo (de la Fuente S et al. Pacing Clin Electrophysiol. 2008;31:916-9). In another study, this variant was reported in conjunction with a nonsense alteration in CASQ2 in a different individual with CPVT (Hong RA et al. Pacing Clin Electrophysiol. 2012;35:794-7). In functional in vitro analyses, this variant has demonstrated loss of selectivity to calcium and aggregation in the presence of magnesium (Bal NC et al. Biochem J. 2011;435:391-9). By internal structural analysis, this variant has been suggested to affect protein alignment and folding in the region (Ambry internal data). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at